The popularity of Viagra initially drove a boom for pharma, however recent shifts present a murky scenario for shareholders. Generic versions are eating into revenue, and ongoing patent challenges add more complexity https://gregoryoamo738370.theobloggers.com/47787375/sildenafil-and-big-pharma-a-volatile-bet